Current, new and future biological agents on the horizon for the treatment of inflammatory bowel diseases

Therapeutic Advances in Gastroenterology
Aurelien Amiot, Laurent Peyrin-Biroulet

Abstract

Biological agents for inflammatory bowel diseases (IBD) targeting tumor necrosis factor (TNF) have changed the way to treat IBD refractory to standard medications and allowed us to reach new therapeutic goals such as mucosal healing and deep remission. A better understanding of the components of the pathological processes that are a hallmark of IBD has led to the development of a new family of biological agents in Crohn's disease and ulcerative colitis. Biosimilars, which are copy versions of currently licensed biological agents, will be soon available. The biosimilar of infliximab is as effective and as safe as its originator in rheumatologic conditions, while a new anti-TNF agent, namely golimumab, has been recently approved for refractory ulcerative colitis. Beyond TNF blockers, anti-adhesion molecules appear to be a potent drug class for IBD. Vedolizumab was recently approved for both Crohn's disease and ulcerative colitis. Numerous other compounds are in the pipeline. Ustekinumab looks very promising for Crohn's disease. Smad7 antisense oligonucleotide might enrich our armamentarium if preliminary data are confirmed in upcoming clinical trials. Herein, we review the efficacy and safety of new and emerging biological agents...Continue Reading

References

Jan 29, 1999·Physiological Reviews·D Vestweber, J E Blanks
Aug 24, 2001·The Journal of Clinical Investigation·G MonteleoneT T MacDonald
Jun 6, 2002·Lancet·Stephen B HanauerUNKNOWN ACCENT I Study Group
Jan 3, 2003·The New England Journal of Medicine·Subrata GhoshUNKNOWN Natalizumab Pan-European Study Group
Oct 16, 2003·International Journal of Pharmaceutics·Daan J A CrommelinWim E Hennink
Jun 11, 2005·The New England Journal of Medicine·Annette Langer-GouldDaniel Pelletier
Jun 11, 2005·The New England Journal of Medicine·B K Kleinschmidt-DeMasters, Kenneth L Tyler
Jun 11, 2005·The New England Journal of Medicine·Gert Van AsschePaul Rutgeerts
Jun 17, 2005·The New England Journal of Medicine·Brian G FeaganMargaret K Vandervoort
Nov 4, 2005·The New England Journal of Medicine·William J SandbornUNKNOWN Evaluation of Natalizumab as Continuous Therapy (ENACT-2) Trial Group
Dec 13, 2005·The New England Journal of Medicine·Paul RutgeertsJean Frédéric Colombel
May 2, 2007·Annals of Internal Medicine·William J SandbornPaul F Pollack
May 4, 2007·Inflammatory Bowel Diseases·Jonas Mudter, Markus F Neurath
May 9, 2007·Gastroenterology·Stephan R TarganUNKNOWN International Efficacy of Natalizumab in Crohn's Disease Response and Remission (ENCORE) Trial Group
Jul 8, 2008·Lancet·Laurent Peyrin-BirouletJean-Frédéric Colombel
Aug 19, 2008·Gastroenterology·William J SandbornUNKNOWN Ustekinumab Crohn's Disease Study Group
Oct 3, 2008·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Brian G FeaganAsit Parikh
Aug 27, 2009·Nature Reviews. Clinical Oncology·Nafees N Malik
Oct 29, 2009·The American Journal of Gastroenterology·Laurent Peyrin-BirouletWilliam J Sandborn
Aug 25, 2010·Best Practice & Research. Clinical Rheumatology·Richard J RieseJoel Kremer
Mar 17, 2011·The American Journal of Gastroenterology·Vincent BillioudLaurent Peyrin-Biroulet
Mar 25, 2011·Kidney International·Kearkiat PraditpornsilpaSomchai Eiam-Ong
May 3, 2011·Gastroenterology·Daniel Burger, Simon Travis
Jun 8, 2011·Gut·Laurent Peyrin-BirouletUNKNOWN International Programme to Develop New Indexes for Crohn's Disease (IPNIC) group
Jan 19, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Giovanni MonteleoneFrancesco Pallone
Mar 16, 2012·The New England Journal of Medicine·Giancarlo ComiUNKNOWN ALLEGRO Study Group
Jul 21, 2012·Nature Immunology·Dario A A Vignali, Vijay K Kuchroo
Aug 17, 2012·The New England Journal of Medicine·William J SandbornUNKNOWN Study A3921063 Investigators
Sep 4, 2012·Gut·Peter Mannon, Walter Reinisch
Oct 19, 2012·The New England Journal of Medicine·William J SandbornUNKNOWN CERTIFI Study Group
Oct 25, 2012·Blood·Martina WeiseChristian K Schneider

❮ Previous
Next ❯

Citations

Jan 15, 2016·Expert Review of Gastroenterology & Hepatology·Federica FurfaroSilvio Danese
Feb 18, 2015·Scandinavian Journal of Gastroenterology·Johan Burisch, Pia Munkholm
Sep 24, 2015·Expert Review of Gastroenterology & Hepatology·Stefan Schreiber
Sep 24, 2015·Expert Review of Gastroenterology & Hepatology·Sang Hyoung ParkSang Joon Lee
Nov 26, 2015·Biologicals : Journal of the International Association of Biological Standardization·Karin MalíčkováMilan Lukáš
Mar 8, 2016·Seminars in Arthritis and Rheumatism·Ewa Olech
Dec 25, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Annika FredeAstrid M Westendorf
Dec 22, 2015·Current Opinion in Pharmacology·Ivana BravatàSilvio Danese
Dec 4, 2015·Gastroenterología y hepatología·María Chaparro, Javier P Gisbert
Nov 26, 2015·The Surgical Clinics of North America·Panayiotis GrevenitisNilesh Lodhia
Sep 26, 2015·European Journal of Pharmacology·Marta ZielińskaJakub Fichna
Sep 21, 2015·Current Gastroenterology Reports·Heba N IskandarFrancis A Farraye
Jun 24, 2015·Current Opinion in Pharmacology·Lucienne Chatenoud
Mar 24, 2016·Scandinavian Journal of Gastroenterology·Radan KeilJulius Špičák
Jun 3, 2016·Journal of Crohn's & Colitis·Tim WyantBrihad Abhyankar
Jul 21, 2016·Biologicals : Journal of the International Association of Biological Standardization·Kornelius SchulzeUlf Helwig
Jul 7, 2016·Journal of Crohn's & Colitis·Kirsty M HooperPaul Henderson
Oct 25, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Mustafa S NaouarAzza Filali
Sep 21, 2016·Current Allergy and Asthma Reports·Marianne Forkel, Jenny Mjösberg
Oct 1, 2016·Expert Review of Clinical Immunology·Daniela PuglieseAlessandro Armuzzi
Nov 4, 2016·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Ira JacobsSadiq Lula
Jan 18, 2017·Expert Review of Clinical Pharmacology·Sean McConachiePramodini B Kale-Pradhan
Jun 9, 2017·Alimentary Pharmacology & Therapeutics·A AmiotUNKNOWN OBSERV-IBD study group and the GETAID
Aug 23, 2017·International Journal of Molecular Sciences·Stephanie ZwickerElisabeth A Boström
Nov 6, 2015·Inflammatory Bowel Diseases·Nilesh ChandeBrian G Feagan
May 23, 2015·The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi·Byung Ik Jang
Nov 18, 2018·Expert Opinion on Therapeutic Patents·Hao LiJi-Fu Wei
Feb 23, 2019·Inflammatory Bowel Diseases·Tawnya M HansenYvette Leung
Apr 25, 2019·Current Gastroenterology Reports·Tushar Shukla, Bruce E Sands
Aug 22, 2020·Clinical and Translational Science·Katharine V RogersSatyaprakash Nayak
Feb 9, 2016·World Journal of Gastroenterology : WJG·Wei-Xin LiuShou-Zhi Gu
Oct 21, 2016·Current Medicinal Chemistry·Laura Martelli, Laurent Peyrin-Biroulet
Mar 10, 2017·World Journal of Gastroenterology : WJG·Lie ZhengZhi-Peng Tang
May 19, 2018·United European Gastroenterology Journal·Martine De VosUNKNOWN Belgian Inflammatory Bowel Disease Research and Development (BIRD)
Sep 29, 2020·Frontiers in Immunology·Mohamed A AlfalehAnwar M Hashem
Feb 23, 2018·The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi·You Sun Kim

❮ Previous
Next ❯

Methods Mentioned

BETA
antisense oligonucleotide

Software Mentioned

Celgene

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.